SPPI - Spectrum Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Spectrum Pharmaceuticals's activity chart (see below) currently has 65 price targets and 64 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 31.48% of the time, taking 255.44 days on average.

Most recent stock forecast was given by from HC WAINWRIGHT on 26-May-2023. First documented stock forecast 07-Mar-2014.

Best performing analysts who are covering SPPI - Spectrum Pharmaceuticals:

Adnan Butt Chris Howerton Mayank Mamtani Alethia Young

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 26-May-2023

3 years 5 months 26 days ago
(26-May-2023)

1/12 (8.33%)

$8.31 (225.20%)

860

Buy Since 15-Mar-2019

$1.5

3 years 6 months 6 days ago
(15-May-2023)

0/2 (0%)

$0.25 (20.00%)

Buy Since 08-May-2023

$1.14

$1

3 years 6 months 13 days ago
(08-May-2023)

2/3 (66.67%)

$0.04 (3.64%)

43

Buy Since 17-Sep-2020

$4

$4

3 years 9 months 15 days ago
(06-Feb-2023)

0/3 (0%)

$3.18 (387.80%)

Hold Since 16-Aug-2021

$17

5 years 3 months 5 days ago
(16-Aug-2021)

0/2 (0%)

$8.25 (94.29%)

Show more analysts

Please expand the browser size to see the chart

What is SPPI (Spectrum Pharmaceuticals) average time for price targets to be met?

On average it took 255 days for the stock forecasts to be reached, with an average price target met ratio of 31.48%.

Which analyst most recently updated their price target on SPPI (Spectrum Pharmaceuticals)?

Which analyst has the most public recommendations on SPPI (Spectrum Pharmaceuticals)?

has 0 price targets and 0 ratings on SPPI

Which analyst is the currently most bullish on SPPI (Spectrum Pharmaceuticals)?

Adnan Butt with the highest potential upside of $36.97

Which analyst is the currently most reserved on SPPI (Spectrum Pharmaceuticals)?

Alethia Young with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?